The abstract is read at the publisher; the summary is JClub's.
NF1 loss in HPV-positive cervical pre-tumoroids accelerates malignant transformation, compressing a 5–10-year process into 3–6 months while enhancing RAS-MAPK and PI3K-AKT signaling.
- Why it matters: Gatekeepers that restrain HPV-driven progression from high-grade squamous intraepithelial lesions to cancer are unclear, limiting prevention and targeted therapy options.
- What they did: The team combined single-cell transcriptomics of patient samples with a focused CRISPR-Cas9 screen in HPV-positive pre-tumoroids, then tested NF1 loss and restoration in organoid models.
- The result: NF1 restoration induced apoptosis and suppressed malignant maintenance, and an AI-designed minimal NF1-mimetic peptide that engages RAS-GTP reduced tumor burden in HPV16-driven mouse models while restoring local immune permissiveness.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.